SCHEMBL4201272

SCHEMBL4201272

Brc1cnc2c(c1)CC[N]C2

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 1/20 0.35
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5120809 0.74 ADRA2A (0.47) ABHD6HTTKMT2A
SCHEMBL9403398 0.74 PRNP (0.46) ABHD6HTTKMT2A
SCHEMBL30471092 0.69 ABHD6 (0.35) ABHD6HTTKMT2A
SCHEMBL3020052 0.68 PNMT (0.46) ABHD6
SCHEMBL2303460 0.68 ASIC3 (0.46) ABHD6
SCHEMBL31394726 0.68 DYRK1A (0.32) ABHD6HTTKMT2A
SCHEMBL29762650 0.68 PNMT (0.50)
SCHEMBL21591692 0.68 PNMT (0.50)
SCHEMBL15309401 0.64 TNKS2 (0.41) ABHD6HTTKMT2A
SCHEMBL29727983 0.64 PNMT (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090062291-A1 PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062291-A1 PHOSPHODIESTERASE 10 INHIBITORS PDE10A, PDE12, PDE5A ABHD6 874/4885HTT 3186/4885KMT2A 2494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.